Alcon Introduces Clareon PanOptix Pro in Canada, Delivering the Lowest Light Scatter of any Trifocal IOL
Article content
Clareon PanOptix Pro has half the light scatter of Clareon PanOptix 1-3,*,**
PanOptix Pro provides an unprecedented 94% light utilization, compared to a theoretical maximum utilization of 96% for diffractive optics 1-4,*,**,†
Clareon PanOptix Pro provides more uninterrupted light distribution across the full visual range, and is designed for better image contrast 1,††,‡
Article content
TORONTO — Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon ® PanOptix ® Pro intraocular lens (IOL) for cataract patients inCanada. PanOptix Pro leverages proprietary ENLIGHTEN ® NXT Optical technology which delivers the lowest light scatter and highest reported light utilization of any trifocal IOL. 1-3,5-9,**,‡‡ PanOptix Pro provides an unprecedented 94% light utilization, compared to a theoretical maximum utilization of 96% for diffractive optics. 1-4,*,**,† These enhancements also provide more uninterrupted light distribution from distance to near, and a 16% increase in optical image contrast between distance and intermediate. 1,††,‡ PanOptix Pro builds on the clinically-proven low visual disturbance profile, high spectacle independence and exceptionally high patient satisfaction of PanOptix. 10-13,§,§§,¶,¶¶ 'Now, with PanOptix Pro, more light utilization and less light scatter is possible‡,‡‡, empowering both my practice and my patients.'
Article content
'As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D,' said Rob Scott, VP, Intraocular Devices, R&D, Alcon. 'Our team looked at hundreds of design options, ultimately landing on a targeted diffractive refinement that helped us recover 50% of light lost to scatter, and reposition it to a beneficial focal point for PanOptix Pro. 1,3,10.14-19,* This allowed for specific enhancements while maintaining the features that have driven the success of PanOptix—the world's most implanted trifocal IOL.' 1-3,20,21,*,**,‡‡,‖,Ω 'PanOptix has been a cornerstone of my cataract practice for eight years,' said Dr. Rosa Braga-Mele, MD, MEd, FRCSC, Professor of Ophthalmology, University of Toronto. 'These lenses have consistently delivered outstanding visual outcomes for my patients 10, 24, § – a low visual disturbance profile 25, ∂ and a happy patient with greater spectacle independence. 23, § So, it's exciting to see this technology evolve to further meet patients' visual expectations. Now, with PanOptix Pro, more light utilization and less light scatter is possible ‡,‡‡, empowering both my practice and my patients.'
Article content
PanOptix Pro will be available in Canada from Alcon in the single-use Clareon AutonoMe ® preloaded delivery system and as well as with the Clareon Monarch ® IV delivery system in early 2026. 22 PanOptix Pro offers a +2.17 diopter intermediate and a +3.25 diopter near add power. Like all Alcon IOLs, PanOptix Pro will be available with blue light and ultraviolet filtering. 22 For surgeons interested in more information on PanOptix Pro, please speak to a local Alcon representative.
Article content
About Clareon PanOptix Pro
Article content
The Clareon PanOptix Pro Trifocal IOL is a type of multifocal IOL used to focus images clearly onto the back of your eye (retina) to allow clear vision after the cataract removal. In addition, the center of the Clareon PanOptix Pro Trifocal IOL allows for better near (reading) vision and intermediate (computer work) vision versus what a monofocal lens would provide. Please consult the Directions for Use regarding indications, precautions, cautions and warnings which is available at ifu.alcon.com.
Article content
About Alcon
Article content
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people's lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.ca.
Article content
* PanOptix has 88% light utilization (12% scatter light)/PanOptix Pro 94% light utilization (6% scatter light).
** Based on manufacturer-reported values and respective methodology for Clareon PanOptix, Envista Envy, AT Elana, Gemetric and Rayner.
† For feasible diffractive optics of up to pentafocal design from Krackhardt et al.
†† Simulated photopic through-focus point spread function (light intensity [energy])—polychromatic.
‡ Compared to Clareon PanOptix.
‡‡ Based on bench and vision simulator studies.
§Based on prospective multicenter randomized study at 6 months, significantly more subjects reported not experiencing starburst and glare (p<0.05 n=276).
§§All-implanted analysis set.
¶In response to the IOLSAT questionnaire question 'In the past 7 days, how often did you need to wear eyeglasses to see'?
¶¶Response to the following question on IOLSAT questionnaire (Version 1.0, December 20, 2018) at 6 months post-op 'Given your vision today, if you had to do it all over, would you have the same lenses implanted again?'; n=127.
‖ Based on worldwide IOL unit sales of Clareon PanOptix and AcrySof IQ PanOptix through Q1, 2024.
Ω Severity ratings by phakic patients with simulated implant of Clareon PanOptix Pro and Clareon PanOptix using VirtIOL simulator (n=64).
∂ Based in a meta-analysis of 11 unique clinical studies with 580 patients in 10 different countries, including 'very bothersome' and 'severe' visual disturbances. Clinical studies were performed on the AcrySof IQ PanOptix IOL; AcrySof IQ PanOptix and Clareon PanOptix are optically equivalent.
Article content
References
Article content
Alcon data on file, 2025. REF-25218
Alcon data on file, 2024. REF-25221
Alcon data on file, 2015. REF-08546
Krackhardt U, et al: Upper bound on the diffraction efficiency of phase-only fanout elements. Applied Optics; 1992; 31:27-37.; 10. Zhu D., Zhang J., et al. Patient-Reported Outcomes of Visual Disturbances with a Trifocal Intraocular Lens: A meta-analysis. Paper presented at: ASCRS Annual Meeting; April 5-8, 2024; Boston.
Muzychuk, A. Defocus Curve Performance of a Novel Hydrophobic Acrylic Trifocal Intraocular Lens: A prospective, Multicenter Canadian Study. ASCRS Annual Meeting, April 5-8, Boston.
Rayner Professional Website. https://rayner.com/en/iol/trifocal/rayone-trifocal/. Accessed September 2024.
Carones F. New Concept of Light Distribution for Bilateral Trifocal IOL Implantation. AAO. 2022;2022:53.
ZEISS AT LISA tri family. Supplement in Cataract and Refractive Surgery Today (Europe), September 2014.
Zeiss Cataract Insights: Laying the Myth or Reality; Digitalization enhances cataract surgery? Supplement in Ophthalmology Times, Europe; May 22, 2024; https://europe.ophthalmologytimes.com/zeiss-cataract-insight-series?page=1. Accessed September 2024.
Kohnen T, Lapid-Gortzak R, Ramamurthy D, et al. Clinical outcomes after bilateral implantation of a diffractive trifocal intraocular lens: A worldwide pooled analysis of prospective clinical investigations. Clinical Ophthalmology. 2023;Volume 17:155-163. doi:10.2147/opth.s377234.
Alcon data on file, 2024. REF-23958.
Alcon data on file, 2018. REF-01475.
Alcon Vision LLC. Clareon® PanOptix® Trifocal Hydrophobic Acrylic IOL. Product Information. 2021.
Charness N, Dijkstra K, Jastrzembski T, Weaver S, Champion M. Monitor viewing distance for younger and older workers. Proceedings of the Human Factors and Ergonomics Society Annual Meeting. 2008;52(19):1614- 1617. doi:10.1177/154193120805201965
Government of Canada CC for OH and S. CCOHS: Office ergonomics. Canadian Centre for Occupational Health and Safety. April 25, 2023. Accessed May 9, 2023. https://www.ccohs.ca/oshanswers/ergonomics/office/.
Gundersen K, Potvin R. Trifocal intraocular lenses: A comparison of the visual performance and quality of vision provided by two different lens designs. Clinical Ophthalmology. 2017;Volume 11:1081-1087. doi:10.2147/opth.s136164
Kohnen T, Titke C, Böhm M. Trifocal intraocular lens implantation to treat visual demands in various distances following lens removal. American Journal of Ophthalmology. 2016;161. doi:10.1016/j.ajo.2015.09.030
Lwowski C, Pawlowicz K, Petermann K, et al. Visual and patient-reported factors leading to satisfaction after implantation of diffractive extended depth-of-focus and trifocal intraocular lenses. Journal of Cataract and Refractive Surgery. 2022;48(4):421-428. doi:10.1097/j.jcrs.0000000000000780
Alcon data on file, 2024. REF-25903
Alcon data on file, 2024. REF-23554
MarketScope LLC. 2023 IOL Market Report: Global Analysis for 2022 to 2028. St. Louis, MO: MarketScope LLC; 2023.
Clareon® PanOptix® Pro Trifocal Hydrophobic Acrylic IOL Model PXYWT0 2024 Directions for Use.
Zhu D, et al. Rate of complete spectacle independence with a trifocal intraocular lens: A systematic literature review and meta-analysis. Ophthalmology and Therapy. 2023;12(2):1157-1171. doi:10.1007/s40123-023-00657-5.Alcon Vision LLC.
Modi S, Lehmann R, Maxwell A, et al. Visual and patient-reported outcomes of a diffractive trifocal intraocular lens compared with those of a monofocal intraocular lens. Ophthalmology. 2021;128(2):197-207. doi:10.1016/j.ophtha.2020.07.015
Zhu D., Zhang J., et al. Patient-Reported Outcomes of Visual Disturbances with a Trifocal Intraocular Lens: A meta-analysis. Paper presented at: ASCRS Annual Meeting; April 5-8, 2024; Boston.
Article content
Article content
Article content
Article content
Article content
Contacts
Article content
Media Relations
Article content
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
38 minutes ago
- Globe and Mail
Should You Buy AmEx Stock After Wall Street Ups Earnings View?
American Express Company AXP is gaining attention as its earnings estimates for 2025 have moved higher over the past week. The company delivered strong first-quarter 2025 earnings, driven by growing Card Member spending and a premium customer base. Rising revolving loan balances and continued robust card fee growth aided its performance. The results were partially offset by escalating customer engagement and operating costs. Analysts Turn Bullish on AmEx Wall Street analysts are turning bullish on the stock, as evident from the earnings estimates' northward revision. Over the past seven days, the Zacks Consensus Estimate for 2025 earnings has increased 1 cent. The Zacks Consensus Estimate for AmEx's 2025 and 2026 earnings indicates 13.9% year-over-year growth each. Similarly, the consensus mark for 2025 and 2026 revenues is pegged at $71.3 billion and $77 billion, respectively, indicating 8.1% and 8% year-over-year growth. It beat earnings estimates in each of the past four quarters, with the average surprise being 5.2%. American Express Company Price and EPS Surprise AmEx's Tailwinds Analysts anticipate that American Express will soon announce a significant increase in the annual fee for its Platinum card, following rival JPMorgan Chase & Co. 's JPM decision to raise the fee on its Sapphire Reserve card by 45% to $795, a record hike among major U.S. credit cards. AmEx is expected to unveil its largest-ever card revamp this fall, marking a substantial investment in its premium offering. Warren Buffett frequently cites AmEx as a prime example of a durable business with a strong competitive moat. Unlike Visa Inc. V and Mastercard Incorporated MA, which operate solely as payment networks, AmEx also functions as a bank, allowing it to generate revenue from both transaction fees and interest on card balances. This integrated model provides a more diversified income stream and enhances its resilience to economic uncertainty. The company is also making notable inroads with younger consumers. Gen X, millennials, and Gen Z now represent a significant share of AmEx's customer base, spending at higher levels than baby boomers and driving long-term growth prospects. Financially, AmEx remains on solid footing. As of the first quarter of 2025, it held $52.5 billion in cash and equivalents against just $1.6 billion in short-term debt. The company returned $7.9 billion to shareholders in 2024 through dividends and buybacks and maintained that momentum in early 2025 with $1.3 billion returned in the first quarter. Additionally, it boosted its quarterly dividend by 17% in March 2025 to 82 cents per share. AmEx's Price Performance & Valuation AmEx stock has gained 9.6% over the past three months, underperforming the industry 's 6.3% decline. Peers like Visaand Mastercardalso witnessed growth, but to a lesser extent. Meanwhile, the S&P 500 has gained 5.5% in the same period. Three-Month Price Performance Comparison – AXP, V, MA, Industry & S&P 500 AXP is currently trading at a premium based on its historical valuation. Its forward P/E ratio stands at 18.31X, above its five-year median of 16.83X, indicating a higher-than-usual market confidence in its growth prospects. However, when compared to peers such as Visa and Mastercard, which trade at forward P/E multiples of 27.53X and 31.27X, respectively, AXP appears relatively attractive. AmEx's Risks American Express continues to grapple with rising expenses, which could weigh on profit growth. Total costs have climbed steadily in recent years, up 22% in 2021, 24% in 2022, 10% in 2023 and 6% in 2024. The trend persisted into the first quarter of 2025, with expenses rising 10% year over year to $12.5 billion. A large portion of these costs stems from customer engagement and marketing efforts, which are expected to remain elevated, putting pressure on margins. Reward expenses and cardmember services remain key cost drivers, comprising nearly 45% of total expenses in 2024. These categories are set to rise further as consumer spending grows. Membership Rewards and cashback payouts have increased in line with higher billed business, while surging travel-related expenditure has also contributed to the jump in rewards expenses. Should You Buy AXP Stock Now? American Express remains fundamentally strong, backed by a premium customer base, diversified revenue streams and a solid balance sheet. Its ability to capture younger demographics and the planned Platinum card revamp offer long-term growth potential. However, rising expenses, especially in rewards and customer engagement, pose margin risks, while the stock's premium valuation versus its historical average tempers near-term upside potential. Although analyst sentiment has improved slightly, with upward estimate revisions for 2025, these positive factors appear largely priced in. Given this balanced risk-reward profile, a Zacks Rank #3 (Hold) seems appropriate, suggesting investors wait for a more attractive entry point. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Zacks Names #1 Semiconductor Stock It's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom. With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028. See This Stock Now for Free >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report JPMorgan Chase & Co. (JPM): Free Stock Analysis Report Mastercard Incorporated (MA): Free Stock Analysis Report Visa Inc. (V): Free Stock Analysis Report American Express Company (AXP): Free Stock Analysis Report
CTV News
an hour ago
- CTV News
Craig's Cookies set to open in Ottawa on Canada Day
Craig's Cookies will open on George Street in the ByWard Market on July 1. (Josh Pringle/CTV News Ottawa) Craig's Cookies will celebrate Canada's birthday with the opening of its first location in Ottawa. The Toronto-based cookie company announced its location on George Street in the ByWard Market on July 1. 'A fitting celebration of Canadian pride, community, and cookies,' Craig's Cookies said in a media release. Craig's Cookies has locations in Toronto, Niagara-on-the-Lake, Collingwood, Niagara Falls, Burlington, Hamilton, London, Windsor and St. John's. According to Craig's Cookies Instagram account, the company is hiring bakers for its Ottawa store. Craig's Cookies is moving into the former location of Quelque Chose Pâtisserie, the store specializing in macarons. The store closed in April after almost eight years in the ByWard Market. Last year, Crumbl Cookies opened its first location in Ottawa at College Square.
CTV News
an hour ago
- CTV News
Mazda Canada CEO David Klan to retire, COO Amy Fleming named successor
A Mazda vehicle logo is pictured at an automotive dealership in Ottawa on Friday, Aug. 11, 2023. THE CANADIAN PRESS/Sean Kilpatrick RICHMOND HILL — Mazda Canada Inc. says president and chief executive David Klan will retire later this year. He will be succeeded by Amy Fleming, the company's chief operating officer, effective Oct. 1. Klan, 33-year veteran of Mazda, held a broad range of executive positions with Japanese automaker globally before taking the top Canadian job in 2019. Fleming joined Mazda Canada in 2006 and has been senior director and chief operating officer since 2023. Based in Richmond Hill, Ont., Mazda Canada is responsible for the sales and marketing, customer service and parts support of Mazda vehicles in the country. It has a network of 163 retail stores across Canada. --- This report by The Canadian Press was first published June 20, 2025.
